biotechnology

Southlake Biotech Renibus Therapeutics Garners $33M in Bridge Financing

by | Dec 8, 2022
Southlake-based Renibus Therapeutics—a clinical-stage biotech company developing innovative products for cardiorenal diseases—has received $33 million in bridge financing to help it advance three drugs in its pipeline. The drugs are currently in various phases of trials.
MORE
R.A. Session II, president, CEO, and founder of Taysha Gene Therapies [Background image: Olena Yepifanova via iStock]
Taysha Gene Therapies Lands $50M Investment from Japanese Firm to Fight Rare Diseases
by | Oct 25, 2022
The investment by Tokyo-based Astellas Pharma gives it a 15% stake in Taysha and positions it to potentially purchase the company, according to the Dallas Morning News. The Dallas-based biotech firm's pipeline includes the "first-and-only" gene therapy in clinical development for Rett syndrome and a Phase 1/2 development of a treatment for an inherited nervous system disorder that's awaiting regulatory feedback.

“We believe this investment not only further validates the potential of our technology platform, but also reinforces the therapeutic and market opportunity of our two lead clinical assets,” Founder and CEO R.A. Sessions II says. 
MORE
Bio Boom: Dallas-Fort Worth Is Emerging as a Hub for Biotech and Life Sciences
by | Nov 27, 2020
Biotechnology is alive and growing in DFW. The region recently ranked 6th on a list of top ten emerging life science clusters in the U.S.
MORE
Caris Life Sciences Raises $310M to Continue Rapidly Growing in the Precision Medicine Market
by | Oct 27, 2020
The growth capital will allow Caris to advance its position as a leading tumor profiling company that aims to reinvent cancer care.
MORE

New Fort Worth Chamber CEO Aims for Growth, Innovation, and Development

by | Sep 22, 2020
CEO Brandom Gengelbach says he’s doing business differently in the fast-growing city “where the West begins.”
MORE
At the Fourth Annual iC3 Life Science Summit at UT Arlington on Oct. 10, 2017 recipient Lyda Hill will present the award. To register for the summit, visit www.bionorthtx.org. [Illustration: bestbrk/istockphoto]
Bio North Texas Shifts iC3 Life Sciences Summit to Virtual Event
by | Sep 22, 2020
Networking—always a highlight of the biotech event— is still a cornerstone thanks to a new virtual conference platform, its organizers said.
MORE
Fort Worth Ophthalmic Biotech Eyevance Exits to Japanese Firm for $225M
by | Sep 17, 2020
Eyevance Pharmaceuticals, which develops and commercializes ophthalmic products, has been purchased for $225 million by Santen, a Japanese leader in ophthalmology. Eyevance will join Santen's U.S. organization.
MORE
CerSci
Dallas-based Biotech CerSci Acquired by ACADIA Pharmaceutical in $52.5M Deal
by | Aug 25, 2020
CerSci shareholders could net another $887 million in milestones and tiered royalties. The clinical-stage startup, which launched in 2015, is developing a new generation of non-opioid meds to treat acute and chronic pain.
MORE

Clinical-Stage Biotech Expands From Silicon Valley to the University of North Texas Health Science Center in Fort Worth

by | Jul 13, 2020
CAGE Bio—currently a resident at Johnson & Johnson Innovation—uses a proprietary platform to develop therapeutic products for dermatology, inflammation, and immunology.
MORE
Study Says: Dallas Biotech’s Antimicrobial Coating Linked with Health Care-Associated Infection Reduction
by | May 4, 2020
Last month, Allied BioScience received capital from Lydia Partners to scale its operations and meet a surging demand.
MORE
Follow the Money: Texas Standard Raises $500K, DCS Global Gets Growth Investment
by | Jun 28, 2018
From Viziv Technologies raising another $576,000 for energy technology and Stryve Foods raising $10 million, here's a look at recent funding and acquisitions involving companies and firms with North Texas ties.
MORE
infectious
BionorthTX Welcomes New President, Board Members
by | Oct 4, 2016
The life science industry association has more than 70 North Texas companies and 20 individuals or job seekers within its membership.
MORE